FSA Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$904K Buy
754
+354
+89% +$362K 0.29% 24
2026
Q1
$368K Buy
+400
New +$406K 0.15% 31

Other funds holding LLY

FSA Investment Group's LLY Position: Q2 2026 in Review

FSA Investment Group increased its Eli Lilly (LLY) stake by 89% in Q2 2026, buying an estimated $362K and bringing the position to 754 shares worth $904K. The position accounts for 0.29% of the portfolio, ranked #24.

FSA Investment Group first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • FSA Investment Group held 754 shares of Eli Lilly worth $904K as of Q2 2026.
  • FSA Investment Group bought 354 Eli Lilly shares in Q2 2026, an estimated $362K.
  • Eli Lilly made up 0.29% of FSA Investment Group's portfolio in Q2 2026, its #24 holding.
  • FSA Investment Group first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on FSA Investment Group's 13F filing for Q2 2026, filed 20 Jul 2026.